These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6605372)

  • 41. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A major crossreactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Expression in relation to age and immunoglobulin G subclass.
    Lucas AH; Granoff DM
    J Clin Invest; 1990 Apr; 85(4):1158-66. PubMed ID: 2318971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b.
    Anderson P; Pichichero ME; Insel RA
    J Pediatr; 1985 Sep; 107(3):346-51. PubMed ID: 3875705
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
    N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.
    Johansson EL; Wassén L; Holmgren J; Jertborn M; Rudin A
    Infect Immun; 2001 Dec; 69(12):7481-6. PubMed ID: 11705923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The intrinsic affinity constant (K) of anticapsular antibody to oligosaccharides of Haemophilus influenzae type b.
    Hetherington SV
    J Immunol; 1988 Jun; 140(11):3966-70. PubMed ID: 3259602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
    Käyhty H; Peltola H; Eskola J
    Pediatr Infect Dis J; 1988 Aug; 7(8):574-7. PubMed ID: 3050853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-hib-hepatitis B combined vaccine in infants.
    Pichichero ME; Voloshen T; Zajac D; Passador S
    J Infect Dis; 1999 Oct; 180(4):1390-3. PubMed ID: 10479180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.
    Granoff DM; Weinberg GA; Shackelford PG
    Pediatr Res; 1988 Aug; 24(2):180-5. PubMed ID: 3263612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro induction of IgG1 and IgG2 secretion by B cells of children who developed invasive haemophilus disease despite vaccination.
    Chacko A; Granoff DM
    Pediatr Res; 1991 Jul; 30(1):124-9. PubMed ID: 1891277
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization.
    Massó F; Paéz A; Arista A; Salmón L; Montaño L
    Arch Med Res; 1996; 27(4):539-45. PubMed ID: 8987192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Haemophilus influenzae type b disease. Incidence in a day-care center.
    Ginsburg CM; McCracken GH; Rae S; Parke JC
    JAMA; 1977 Aug; 238(7):604-7. PubMed ID: 301947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
    Madore DV; Johnson CL; Phipps DC; Myers MG; Eby R; Smith DH
    Pediatrics; 1990 Oct; 86(4):527-34. PubMed ID: 2216616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b.
    Smith DH; Peter G; Ingram DL; Harding AL; Anderson P
    Pediatrics; 1973 Nov; 52(5):637-44. PubMed ID: 4542777
    [No Abstract]   [Full Text] [Related]  

  • 55. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
    Käyhty H; Karanko V; Peltola H; Mäkelä PH
    Pediatrics; 1984 Nov; 74(5):857-65. PubMed ID: 6387614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults.
    Granoff DM; Boies EG; Munson RS
    J Pediatr; 1984 Jul; 105(1):22-7. PubMed ID: 6610736
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccine-induced human antibody responses to the Haemophilus influenzae b polysaccharide in severe combined immunodeficient mice engrafted with human leukocytes.
    Lucas AH; Siff TE; Trujillo KH; Kitamura MY
    Pediatr Res; 1992 Jul; 32(1):132-5. PubMed ID: 1635839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Wong VK; Quagliata R; Adler R; Kim KS
    Am J Dis Child; 1991 Jul; 145(7):742-5. PubMed ID: 2058604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
    Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
    Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine.
    Schmitt HJ; Maechler G; Habermehl P; Knuf M; Saenger R; Begg N; Boutriau D
    Clin Vaccine Immunol; 2007 Apr; 14(4):426-34. PubMed ID: 17287313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.